| Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia JA Burger, A Tedeschi, PM Barr, T Robak, C Owen, P Ghia, O Bairey, ... New England Journal of Medicine 373 (25), 2425-2437, 2015 | 1696 | 2015 |
| Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study JA Burger, PM Barr, T Robak, C Owen, P Ghia, A Tedeschi, O Bairey, ... Leukemia 34 (3), 787-798, 2020 | 475 | 2020 |
| Role and prognostic significance of the Ki‐67 index in non‐Hodgkin's lymphoma A Broyde, O Boycov, Y Strenov, E Okon, O Shpilberg, O Bairey American journal of hematology 84 (6), 338-343, 2009 | 209 | 2009 |
| First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)—a systematic review and individual patient data meta-analysis B Kasenda, AJM Ferreri, E Marturano, D Forst, J Bromberg, ... Annals of Oncology 26 (7), 1305-1313, 2015 | 187 | 2015 |
| Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions AJM Ferreri, GP Dognini, E Campo, R Willemze, JF Seymour, O Bairey, ... haematologica 92 (4), 486-492, 2007 | 185 | 2007 |
| Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature O Wolach, O Bairey, M Lahav Medicine 89 (5), 308-318, 2010 | 182 | 2010 |
| Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma C Perry, Y Herishanu, U Metzer, O Bairey, R Ruchlemer, L Trejo, ... European journal of haematology 79 (3), 205-209, 2007 | 168 | 2007 |
| Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes I Hazan-Halevy, D Rosenblum, S Weinstein, O Bairey, P Raanani, D Peer Cancer letters 364 (1), 59-69, 2015 | 154 | 2015 |
| Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2 PM Barr, T Robak, C Owen, A Tedeschi, O Bairey, NL Bartlett, JA Burger, ... haematologica 103 (9), 1502, 2018 | 145 | 2018 |
| Orbital and adnexal involvement in systemic non‐Hodgkin's lymphoma O Bairey, I Kremer, E Rakowsky, H Hadar, M Shaklai Cancer 73 (9), 2395-2399, 1994 | 132 | 1994 |
| Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia PM Barr, C Owen, T Robak, A Tedeschi, O Bairey, JA Burger, P Hillmen, ... Blood advances 6 (11), 3440-3450, 2022 | 130 | 2022 |
| Non-Hodgkin's lymphomas of the colon O Bairey, R Ruchlemer, O Shpilberg IMAJ-RAMAT GAN- 8 (12), 832, 2006 | 121 | 2006 |
| The addition of rituximab to anthracycline‐based chemotherapy significantly improves outcome in ‘Western’patients with intravascular large B‐cell lymphoma AJM Ferreri, GP Dognini, O Bairey, A Szomor, C Montalbán, B Horvath, ... British journal of haematology 143 (2), 253-257, 2008 | 117 | 2008 |
| Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination Y Herishanu, G Rahav, S Levi, A Braester, G Itchaki, O Bairey, N Dally, ... Blood, The Journal of the American Society of Hematology 139 (5), 678-685, 2022 | 105 | 2022 |
| All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells O Bairey, O Boycov, E Kaganovsky, Y Zimra, M Shaklai, E Rabizadeh Leukemia research 28 (3), 243-248, 2004 | 102 | 2004 |
| Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia O Benjamini, L Rokach, G Itchaki, A Braester, L Shvidel, N Goldschmidt, ... Haematologica 107 (3), 625, 2022 | 99 | 2022 |
| Serum albumin level at diagnosis of diffuse large B‐cell lymphoma: an important simple prognostic factor O Bairey, A Shacham‐Abulafia, O Shpilberg, R Gurion Hematological oncology 34 (4), 184-192, 2016 | 96 | 2016 |
| Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies S Weinstein, IA Toker, R Emmanuel, S Ramishetti, I Hazan-Halevy, ... Proceedings of the National Academy of Sciences 113 (1), E16-E22, 2016 | 93 | 2016 |
| Bcl-2, Bcl-X, Bax, and Bak expression in short-and long-lived patients with diffuse large B-cell lymphomas O Bairey, Y Zimra, M Shaklai, E Okon, E Rabizadeh Clinical cancer research 5 (10), 2860-2866, 1999 | 93 | 1999 |
| Increased thromboembolic events after lung transplantation G Izbicki, O Bairey, D Shitrit, J Lahav, MR Kramer Chest 129 (2), 412-416, 2006 | 80 | 2006 |
